Abbott weak medical device sales, China impact drag shares down nearly 7 percent

Published On 2022-10-25 06:30 GMT   |   Update On 2022-10-25 06:30 GMT
Advertisement

New Delhi: Abbott Laboratories on Wednesday reported lower-than-expected growth in international medical device sales, hit by a strong dollar and supply challenges in China, dragging down shares of the company nearly 7%.

The U.S.-based company's weak medical device sales in markets outside its home country offset the initial enthusiasm over its quarterly beat and an upbeat forecast.

Abbott reported $3.62 billion in overall medical device sales, down 0.5% from last year, as the company faced supply challenges due to lockdowns in China.

Advertisement

J.P. Morgan analyst Robbie Marcus says the issues plaguing the medical device segment "could bleed a bit into" the first quarter next year as well.

Multinational companies such as Abbott and Johnson & Johnson have been hit by the dollar's strength against a basket of currencies, including the sterling and the yen, after the U.S. Federal Reserve ramped up interest rates to tame inflation.

Illinois-based Abbott reported third-quarter worldwide sales of $10.4 billion, down 4.7% from a year ago.

Excluding the foreign exchange impact, overall sales were up 1.3%, while the medical device segment saw 6.4% growth.

COVID-19 test kit sales were $1.7 billion, compared to $2.3 billion in the second quarter, as testing declined amid a slower pace of infections.

Abbott said it expects around $7.8 billion in COVID-19 test sales this year, with $500 million in the fourth quarter, compared to the $6.1 billion it had forecast earlier.

Medical device makers such as Abbott have relied on COVID-19 tests to bring in sales during the peak of the pandemic. However, demand has been slowing as more people get vaccinated and overall cases stabilize.

Abbott's stock had declined 25% this year through Tuesday, as the company also struggled with a shutdown of its baby formula facility at Sturgis, Michigan

Read also: Abbott launches Amplatzer Talisman PFO Occlusion System in Europe to close hole in heart for people at risk of recurrent stroke

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News